Neurology
Motor Neurone Disease: Investigating if specific toxins contribute towards to the onset of MND
Research Objectives
Status
Completed
Recruitment
Closed
Study location
Wesley Research Institute, The University of Queensland
Study type
Investigator Initiated
Lead investigator
- Prof Pamela McCombe (UQ)
Experienced investigator
- Dr Aven Lee (UQ)
About this research project
Motor neurone disease (MND) is a severe disease for which there is no successful therapy. Currently there is no cure for MND. The best approach in clinical practice is primary prevention through the modification of risk factors.
In a novel study previously funded by Wesley Research Institute, we have demonstrated that MND patients have increased levels of homocysteine sulfinic acid, an excitotoxin that can be produced by the gut microbiota.
In this follow up study, we will investigate if the increases in these excitotoxins change during disease progression and correlate with survival. These toxins could contribute to the onset of MND. It’s possible that eliminating these gut toxins could lead to better patient outcomes.
Latest News
Breath of fresh air for Clinical Trial participant, Tim
Husband and father of three Tim, was diagnosed with Chronic Obstructive Pulmonary Disease, sometimes known as emphysema, in 2019, when he was 56 years old. Tim participated in a trial for patients with severe emphysema, undergoing two minimally invasive procedures, aimed at improving his lung function.
Coeliac Disease Webinar Series
Are you or a loved one living with coeliac disease? Join us for an engaging and informative webinar designed to explore the challenges, breakthroughs and future pathways in managing this complex disease. Kicking off on Tuesday, 28 January 2025, the first webinar, Living with Coeliac Disease – Pathways to Treatment.
QSBC researchers shine at Multi-Omics 2024!
Queensland Spatial Biology Centre researchers had an action-packed few days at the Multi-Omics 2024 conference held in Brisbane last week.